Concepedia
Statistics
Publications
59
Citations
2.6K
H-Index
29
Active since
1983
Affiliations
AstraZeneca (Sweden)(Current)
AstraZeneca (United Kingdom)
Uppsala University
Sahlgrenska University Hospital
AstraZeneca (United States)
Ulf G. Eriksson is an author at AstraZeneca (Sweden) specializing in medicine, pharmacology, and pharmacotherapy.
Top concepts
MedicinePharmacologyPharmacotherapyThrombosisPharmacokineticsHematologyBiochemistryDrug DiscoveryCardiovascular DiseaseHepatology
Publications per year
1983–2021
The Direct Thrombin Inhibitor Melagatran and Its Oral Prodrug H 376/95: Intestinal Absorption Properties, Biochemical and Pharmacodynamic Effects
David Gustafsson, Jan-Erik Nyström, Stefan Carlsson et al. · Thrombosis Research · 2001 · 302 citations
Pharmaceutical Science, Biochemistry, Medicine +5
Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice.
A Miniscalco, Jonas Lundahl, C G Regårdh et al. · Journal of Pharmacology and Experimental Therapeutics · 1992 · 180 citations
Absorption, Distribution, Metabolism, and Excretion of Ximelagatran, an Oral Direct Thrombin Inhibitor, in Rats, Dogs, and Humans
Ulf G. Eriksson, Ulf Bredberg, Kurt‐Jürgen Hoffmann et al. · Drug Metabolism and Disposition · 2003 · 154 citations
Pharmacokinetics and pharmacodynamics of ximelagatran, a novel oral direct thrombin inhibitor, in young healthy male subjects
Ulf G. Eriksson, Ulf Bredberg, Kristina Gislén et al. · European Journal of Clinical Pharmacology · 2003 · 138 citations
Molecular Pharmacology, Thrombosis, Hematology +6
Ximelagatran, an Oral Direct Thrombin Inhibitor, Has a Low Potential for Cytochrome P450-Mediated Drug-Drug Interactions
Eva Bredberg, Tommy B. Andersson, Lars Frison et al. · Clinical Pharmacokinetics · 2003 · 96 citations
Pharmacological Study, Biochemistry, Medicine +6
1–5 of 59